Myogenetic Oligodeoxynucleotide (myoDN) Recovers the Differentiation of Skeletal Muscle Myoblasts Deteriorated by Diabetes Mellitus

Skeletal muscle wasting in patients with diabetes mellitus (DM) is a complication of decreased muscle mass and strength, and is a serious risk factor that may result in mortality. Deteriorated differentiation of muscle precursor cells, called myoblasts, in DM patients is considered to be one of the...

Full description

Bibliographic Details
Main Authors: Shunichi Nakamura, Shinichi Yonekura, Takeshi Shimosato, Tomohide Takaya
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Physiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphys.2021.679152/full
_version_ 1831750031700393984
author Shunichi Nakamura
Shinichi Yonekura
Shinichi Yonekura
Takeshi Shimosato
Takeshi Shimosato
Takeshi Shimosato
Tomohide Takaya
Tomohide Takaya
Tomohide Takaya
author_facet Shunichi Nakamura
Shinichi Yonekura
Shinichi Yonekura
Takeshi Shimosato
Takeshi Shimosato
Takeshi Shimosato
Tomohide Takaya
Tomohide Takaya
Tomohide Takaya
author_sort Shunichi Nakamura
collection DOAJ
description Skeletal muscle wasting in patients with diabetes mellitus (DM) is a complication of decreased muscle mass and strength, and is a serious risk factor that may result in mortality. Deteriorated differentiation of muscle precursor cells, called myoblasts, in DM patients is considered to be one of the causes of muscle wasting. We recently developed myogenetic oligodeoxynucleotides (myoDNs), which are 18-base single-strand DNAs that promote myoblast differentiation by targeting nucleolin. Herein, we report the applicability of a myoDN, iSN04, to myoblasts isolated from patients with type 1 and type 2 DM. Myogenesis of DM myoblasts was exacerbated concordantly with a delayed shift of myogenic transcription and induction of interleukins. Analogous phenotypes were reproduced in healthy myoblasts cultured with excessive glucose or palmitic acid, mimicking hyperglycemia or hyperlipidemia. iSN04 treatment recovered the deteriorated differentiation of plural DM myoblasts by downregulating myostatin and interleukin-8 (IL-8). iSN04 also ameliorated the impaired myogenic differentiation induced by glucose or palmitic acid. These results demonstrate that myoDNs can directly facilitate myoblast differentiation in DM patients, making them novel candidates for nucleic acid drugs to treat muscle wasting in patients with DM.
first_indexed 2024-12-21T22:20:04Z
format Article
id doaj.art-e05a08e193f34236a3e14ab3fd4ca334
institution Directory Open Access Journal
issn 1664-042X
language English
last_indexed 2024-12-21T22:20:04Z
publishDate 2021-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Physiology
spelling doaj.art-e05a08e193f34236a3e14ab3fd4ca3342022-12-21T18:48:21ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2021-05-011210.3389/fphys.2021.679152679152Myogenetic Oligodeoxynucleotide (myoDN) Recovers the Differentiation of Skeletal Muscle Myoblasts Deteriorated by Diabetes MellitusShunichi Nakamura0Shinichi Yonekura1Shinichi Yonekura2Takeshi Shimosato3Takeshi Shimosato4Takeshi Shimosato5Tomohide Takaya6Tomohide Takaya7Tomohide Takaya8Department of Agriculture, Graduate School of Science and Technology, Shinshu University, Nagano, JapanDepartment of Agricultural and Life Sciences, Faculty of Agriculture, Shinshu University, Nagano, JapanDepartment of Biomolecular Innovation, Institute for Biomedical Sciences, Shinshu University, Nagano, JapanDepartment of Agriculture, Graduate School of Science and Technology, Shinshu University, Nagano, JapanDepartment of Agricultural and Life Sciences, Faculty of Agriculture, Shinshu University, Nagano, JapanDepartment of Biomolecular Innovation, Institute for Biomedical Sciences, Shinshu University, Nagano, JapanDepartment of Agriculture, Graduate School of Science and Technology, Shinshu University, Nagano, JapanDepartment of Agricultural and Life Sciences, Faculty of Agriculture, Shinshu University, Nagano, JapanDepartment of Biomolecular Innovation, Institute for Biomedical Sciences, Shinshu University, Nagano, JapanSkeletal muscle wasting in patients with diabetes mellitus (DM) is a complication of decreased muscle mass and strength, and is a serious risk factor that may result in mortality. Deteriorated differentiation of muscle precursor cells, called myoblasts, in DM patients is considered to be one of the causes of muscle wasting. We recently developed myogenetic oligodeoxynucleotides (myoDNs), which are 18-base single-strand DNAs that promote myoblast differentiation by targeting nucleolin. Herein, we report the applicability of a myoDN, iSN04, to myoblasts isolated from patients with type 1 and type 2 DM. Myogenesis of DM myoblasts was exacerbated concordantly with a delayed shift of myogenic transcription and induction of interleukins. Analogous phenotypes were reproduced in healthy myoblasts cultured with excessive glucose or palmitic acid, mimicking hyperglycemia or hyperlipidemia. iSN04 treatment recovered the deteriorated differentiation of plural DM myoblasts by downregulating myostatin and interleukin-8 (IL-8). iSN04 also ameliorated the impaired myogenic differentiation induced by glucose or palmitic acid. These results demonstrate that myoDNs can directly facilitate myoblast differentiation in DM patients, making them novel candidates for nucleic acid drugs to treat muscle wasting in patients with DM.https://www.frontiersin.org/articles/10.3389/fphys.2021.679152/fullmyogenetic oligodeoxynucleotideskeletal musclemyoblastmyogenic differentiationdiabetes mellitus
spellingShingle Shunichi Nakamura
Shinichi Yonekura
Shinichi Yonekura
Takeshi Shimosato
Takeshi Shimosato
Takeshi Shimosato
Tomohide Takaya
Tomohide Takaya
Tomohide Takaya
Myogenetic Oligodeoxynucleotide (myoDN) Recovers the Differentiation of Skeletal Muscle Myoblasts Deteriorated by Diabetes Mellitus
Frontiers in Physiology
myogenetic oligodeoxynucleotide
skeletal muscle
myoblast
myogenic differentiation
diabetes mellitus
title Myogenetic Oligodeoxynucleotide (myoDN) Recovers the Differentiation of Skeletal Muscle Myoblasts Deteriorated by Diabetes Mellitus
title_full Myogenetic Oligodeoxynucleotide (myoDN) Recovers the Differentiation of Skeletal Muscle Myoblasts Deteriorated by Diabetes Mellitus
title_fullStr Myogenetic Oligodeoxynucleotide (myoDN) Recovers the Differentiation of Skeletal Muscle Myoblasts Deteriorated by Diabetes Mellitus
title_full_unstemmed Myogenetic Oligodeoxynucleotide (myoDN) Recovers the Differentiation of Skeletal Muscle Myoblasts Deteriorated by Diabetes Mellitus
title_short Myogenetic Oligodeoxynucleotide (myoDN) Recovers the Differentiation of Skeletal Muscle Myoblasts Deteriorated by Diabetes Mellitus
title_sort myogenetic oligodeoxynucleotide myodn recovers the differentiation of skeletal muscle myoblasts deteriorated by diabetes mellitus
topic myogenetic oligodeoxynucleotide
skeletal muscle
myoblast
myogenic differentiation
diabetes mellitus
url https://www.frontiersin.org/articles/10.3389/fphys.2021.679152/full
work_keys_str_mv AT shunichinakamura myogeneticoligodeoxynucleotidemyodnrecoversthedifferentiationofskeletalmusclemyoblastsdeterioratedbydiabetesmellitus
AT shinichiyonekura myogeneticoligodeoxynucleotidemyodnrecoversthedifferentiationofskeletalmusclemyoblastsdeterioratedbydiabetesmellitus
AT shinichiyonekura myogeneticoligodeoxynucleotidemyodnrecoversthedifferentiationofskeletalmusclemyoblastsdeterioratedbydiabetesmellitus
AT takeshishimosato myogeneticoligodeoxynucleotidemyodnrecoversthedifferentiationofskeletalmusclemyoblastsdeterioratedbydiabetesmellitus
AT takeshishimosato myogeneticoligodeoxynucleotidemyodnrecoversthedifferentiationofskeletalmusclemyoblastsdeterioratedbydiabetesmellitus
AT takeshishimosato myogeneticoligodeoxynucleotidemyodnrecoversthedifferentiationofskeletalmusclemyoblastsdeterioratedbydiabetesmellitus
AT tomohidetakaya myogeneticoligodeoxynucleotidemyodnrecoversthedifferentiationofskeletalmusclemyoblastsdeterioratedbydiabetesmellitus
AT tomohidetakaya myogeneticoligodeoxynucleotidemyodnrecoversthedifferentiationofskeletalmusclemyoblastsdeterioratedbydiabetesmellitus
AT tomohidetakaya myogeneticoligodeoxynucleotidemyodnrecoversthedifferentiationofskeletalmusclemyoblastsdeterioratedbydiabetesmellitus